Liu, Yanli
Wu, Zhong
Zhou, Jin
Ramadurai, Dinesh K. A.
Mortenson, Katelyn L. http://orcid.org/0000-0002-4239-4840
Aguilera-Jimenez, Estrella http://orcid.org/0000-0002-4160-2855
Yan, Yifei
Yang, Xiaojun
Taylor, Alison M.
Varley, Katherine E.
Gertz, Jason
Choi, Peter S.
Cherniack, Andrew D. http://orcid.org/0000-0003-0470-0111
Chen, Xingdong
Bass, Adam J. http://orcid.org/0000-0002-8193-4758
Bailey, Swneke D. http://orcid.org/0000-0003-3778-8391
Zhang, Xiaoyang http://orcid.org/0000-0002-0031-0290
Funding for this research was provided by:
National Natural Science Foundation of China (82073637, 82122060)
Article History
Received: 1 March 2021
Accepted: 1 November 2021
First Online: 8 December 2021
Competing interests
: E.A.-J. is employed at Recursion Pharmaceuticals. K.E.V. is a cofounder and consultant for Kailos Genetics. A.M.T. receives research funding from Ono Pharmaceutical. A.D.C. receives research funding from Bayer. A.J.B. receives research funding from Bayer, Merck, and Novartis, serves as a consultant to Earli and HelixNano, and is a cofounder of Signet Therapeutics. The other authors declare no competing interests.